Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination with Ipilimumab Versus Ipilimumab Alone in Patients with Advanced Refractory Melanoma (ILLUMINATE-301).Adi Diab,Paolo A Ascierto,Michele Maio,Reham Abdel-Wahab,Sylvie Negrier,Laurent Mortier, Petr Arenberger,Stephane Dalle,Ivana Krajsova,Luis de la Cruz,Marie-Therese Leccia,Michele Guida,Celeste Lebbe,Jean-Jacques Grob,Marcus O Butler,Gino K In,Carmen Loquai,John W T Walker,Victoria Atkinson,Ellen Kapiteijn,Sebastian Haferkamp,Srinivas Chunduru, Shahram Rahimian,Massimo Guidoboni,Caroline RobertJournal of clinical oncology official journal of the American Society of Clinical Oncology（2025）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
